1-2 of 2
Philip Connor, MD
Close
Sort by
Journal Articles

PETIT and PETIT 2: Treatment with Eltrombopag in 171 Children with Chronic Immune Thrombocytopenia (ITP)

James B. Bussel, MD, John D. Grainger, MD BMBch, MRCP, FRCPATH, Purificacion Garcia de Miguel, Jenny M. Despotovic, DO, MS, Franco Locatelli, Thirachit Chotsampancharoen, MD, Elena K. Donyush, Julian Sevilla Navarro, MD, Bunchoo Pongtanakul, MD, Patcharee Komvilaisak, MD, Darintr Sosothikul, MD, Victor S. Blanchette, MD FRCPC, Guillermo I. Drelichman, MD, Lakshmanan Krishnamurti, MD, Nongnuch Sirachainan, MD, Philip Connor, MD, Michele David, MD FRCPC, Susanne Holzhauer, MD MSc, Vladimir Lebedev, Richard S. Lemons, MD PhD, Dagmar Pospisilova, MD PhD, Ugo Ramenghi, MD, Koh B. Boayue, MD, Dana C. Matthews, MD, Lisa M. Marcello, BA, MS, Malini Iyengar, PhD, Geoffrey W. Chan, MD, Karen D. Chagin, MD, Dickens Theodore, MD MPH, Kalpana K. Bakshi, BS, MS, Christine K. Bailey, PhD
Journal: Blood
Blood (2014) 124 (21): 1450.
https://doi.org/10.1182/blood.V124.21.1450.1450
Published: 2014
Journal Articles

Thrombopoietin Receptor Agonists in Paediatric ITP Patients: Long Term Follow up Data in 34 Patients

John D. Grainger, MD BMBch, MRCP, FRCPATH, David J M Routledge, MRCP, MBChB, BSc (Hons), Alexandra Kruse, Philip Connor, MD, Keith Sibson, Tina T Biss, MD, James B. Bussel, MD
Journal: Blood
Blood (2014) 124 (21): 4206.
https://doi.org/10.1182/blood.V124.21.4206.4206
Published: 2014